"As a professional in hormone research, I want to respond to the needs of people suffering from thinning hair."
With that in mind, we are working on the development of a hair hormone test.
There are other ways to measure the risk of AGA besides hair, but we can measure with high accuracy by using a measurement method with excellent selectivity and specificity.
* Accuracy of 1-day reproducibility|within 15%
※.2-day difference reproducibility accuracy|100% ± 15% as a guideline
In addition, from the analysis data of more than 1,400 cases since the launch of the "Hair Hormone Amount Measurement Kit", it has been confirmed that oral medication lowers DHT levels in those who are undergoing AGA treatment.
[About the concentration of DHT in the hair of 1,414 purchasers of this product]
For 1,414 patients who purchased this product and submitted hair samples, the DHT concentration from the hair was measured by the LC-MS/MS method.
In addition, subjects in which finasteride (FIN) and dutasteride (DUT), which inhibit DHT production, were detected as drug takers, and the concentration of DHT in the hair of each group was compared by dividing them into the following four groups.
As a result, the concentration of DHT in the hair in each group was as follows.
Compared to the non-drug group, the drug group showed significantly lower levels in both groups.
In addition, all of the drug groups were at a concentration of almost Stage 1 (upper limit: 2.14 pg/mg) at the risk level set by this kit.